Hologic Announces Financial Results for Third Quarter of Fiscal 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
Hologic (HOLX) PT Raised to $95 at JPMorgan
July 30, 2024 5:11 AM EDTJPMorgan analyst Casey Woodring raised the price target on Hologic (NASDAQ: HOLX) to $95.00 (from $91.00) while maintaining a Neutral rating.
The analyst comments "After the close, Hologic (HOLX) reported a F3Q24 beat, with revenues of $1.011B coming in above the Street of $1.001B and revenue dollar guidance of $992.5M-1.008B, representing+3.8% organic cc growth (vs. Street of +2.7%) and organic ex-COVID cc growth of +5.8% vs. guide of +4.0-5.6%. Moving down the P&L, adj. OPM of 31.2% came in slightly above the Street of 31.1%, with adj. EPS of $1.06 beating the Street of $1.02 and guide of... More
